secwatch.observer — SEC 8-K summary
======================================

Issuer:     Entrada Therapeutics, Inc. (TRDA)
CIK:        0001689375
Form:       8-K
Filed at:   2023-06-08T23:59:59+00:00
Accession:  0001104659-23-069464
Event type: leadership
Sentiment:  neutral
Materiality: 0.25
Item codes: 5.02, 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Director Todd Foley resigns; stockholders elect Kim, Zeiher to board, ratify EY
-------------------------------------------------------------------------------

- Todd Foley resigned from the Board effective June 7, 2023; no disagreement with company operations.
- At 2023 Annual Meeting, Peter S. Kim, Ph.D. and Bernhardt Zeiher, M.D. elected as Class II directors.
- Votes: Kim 24,512,848 for, Zeiher 24,696,429 for; broker non-votes of 1,876,971 each.
- Ratification of EY as independent auditor for FY2023 passed: 26,634,250 for, 606 against, 10 abstain.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1689375/000110465923069464/0001104659-23-069464-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1689375/000110465923069464/tm2318297d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-069464

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer